Is Senolytic Therapy in Cardiovascular Diseases Ready for Translation to Clinics? DOI Creative Commons
Zhihong Yang, Duilio Michele Potenza, Xiu‐Fen Ming

и другие.

Biomolecules, Год журнала: 2025, Номер 15(4), С. 545 - 545

Опубликована: Апрель 8, 2025

Aging is a predominant risk factor for cardiovascular diseases. There evidence demonstrating that senescent cells not only play significant role in organism aging but also contribute to the pathogenesis of diseases younger ages. Encouraged by recent findings elimination pharmacogenetic tools could slow down and even reverse animal models, senolytic drugs have been developed, translation results from basic research clinical settings has initiated. Because numerous studies literature show beneficial therapeutic effects targeting cardiomyopathies associated with ischemia/reperfusion atherosclerotic vascular disease, are considered next generation therapies disorders. However, reported controversial or detrimental caused approaches, including worsening cardiac dysfunction, instability plaques, an increase mortality which challenges therapy into practice. This brief review article will focus on (1) analyzing discussing approaches (2) future directions questions essential understand controversies translate preclinical

Язык: Английский

Molecular fingerprints of cardiovascular toxicities of immune checkpoint inhibitors DOI Creative Commons
Tamás G. Gergely, Zsófia D. Drobni, Nabil V. Sayour

и другие.

Basic Research in Cardiology, Год журнала: 2024, Номер unknown

Опубликована: Июль 17, 2024

Abstract Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by unleashing the power of immune system against malignant cells. However, their use is associated with a spectrum adverse effects, including cardiovascular complications, which can pose significant clinical challenges. Several mechanisms contribute to toxicity ICIs. First, dysregulation checkpoints, such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein-1 (PD-1) its ligand (PD-L1), molecular mimicry cardiac autoantigens, leads immune-related events, myocarditis vasculitis. These events result from aberrant activation T cells self-antigens within myocardium or vascular endothelium. Second, disruption homeostasis ICIs lead autoimmune-mediated inflammation tissues, manifesting dysfunction heart failure, arrhythmias, pericarditis. Furthermore, upregulation inflammatory cytokines, particularly tumor necrosis factor-alpha, interferon-γ, interleukin-1β, interleukin-6, interleukin-17 contributes endothelial dysfunction, plaque destabilization, thrombosis, exacerbating risk on long term. Understanding intricate side effects induced crucial for optimizing patient care ensure safe effective integration immunotherapy into broader range treatment protocols. The implications these underscore importance vigilant monitoring early detection in patients receiving Future key pathological mediators biomarkers may aid prompt diagnosis cardiotoxicity will allow timely interventions.

Язык: Английский

Процитировано

14

Circadian biology of cardiac aging DOI

Sharanya S. Bettadapura,

William D. Todd, Graham R. McGinnis

и другие.

Journal of Molecular and Cellular Cardiology, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Differential Susceptibility to Particulate Matter-Induced Cardiac Remodeling and Senescence: A Comparative Study in Young and Aged Mice DOI Creative Commons
Dunia Waked,

G. H. Guedes,

Rubens Arantes Macedo

и другие.

Atmosphere, Год журнала: 2025, Номер 16(1), С. 109 - 109

Опубликована: Янв. 19, 2025

Background: Epidemiological and toxicological studies have shown that inhalation of particulate matter (PM), a major component air pollution, is associated with the development cardiovascular diseases (CVDs). Cellular senescence other aging mechanisms are also key factors in progression CVD. This study aims to investigate age-related susceptibility cardiac remodeling due PM exposure. Methods: Young old male C57BL/6 mice were exposed filtered or polluted for six months using an ambient particle concentrator. Cardiac hypertrophy, fibrosis, markers cellular (p53, p21, p-H2AX, lipofuscin) myocardium evaluated experimental groups. Results: exposure induces signs remodeling, including cardiomyocyte enlargement increased young mice, along elevated p53 expression. However, no significant alterations structure observed between aged not PM. Conclusions: Our indicates younger individuals may be more vulnerable effects chronic than older later. Further needed explore detailed this age-dependent response.

Язык: Английский

Процитировано

0

Long-term dietary allyl isothiocyanate, a TRPA1 agonist, ameliorates cardiac fibrosis and diastolic dysfunction in aged mice DOI
Chunqi Qian,

Zachary Fernandez,

Seyed Amir Sadeghi

и другие.

GeroScience, Год журнала: 2025, Номер unknown

Опубликована: Март 12, 2025

Язык: Английский

Процитировано

0

Exercise‐Induced Cardiac Lymphatic Remodeling Mitigates Inflammation in the Aging Heart DOI Creative Commons
Kangsan Roh, Haobo Li, Rebecca Freeman

и другие.

Aging Cell, Год журнала: 2025, Номер unknown

Опубликована: Март 13, 2025

ABSTRACT The lymphatic vasculature plays essential roles in fluid balance, immunity, and lipid transport. Chronic, low‐grade inflammation peripheral tissues develops when structure or function is impaired, as observed during aging. While aging has been associated with a broad range of heart pathophysiology, its effect on cardiac not characterized. Here, we analyzed lymphatics aged 20‐month‐old mice versus young 2‐month‐old mice. Aged hearts showed reduced vascular density, more dilated vessels, increased fibrosis peri‐lymphatic zones. As exercise shown benefits several different models age‐related disease, further investigated the effects aerobic training lymphatics. Eight weeks voluntary wheel running attenuated age‐associated adverse remodeling lymphatics, including reversing their dilation, increasing lymph vessel density branching, reducing perilymphatic fibrosis. Intravital lymphangiography demonstrated improved flow after training. Our findings illustrate that leads to dysfunction, can improve health animals.

Язык: Английский

Процитировано

0

Impact of plant-derived antioxidants on heart aging: a mechanistic outlook DOI Creative Commons
Muneer Ahmed Khoso, Heng Liu, Tong Zhao

и другие.

Frontiers in Pharmacology, Год журнала: 2025, Номер 16

Опубликована: Март 21, 2025

Heart aging involves a complex interplay of genetic and environmental influences, leading to gradual deterioration cardiovascular integrity function. Age-related physiological changes, including ventricular hypertrophy, diastolic dysfunction, myocardial fibrosis, increased arterial stiffness, endothelial are influenced by key mechanisms like autophagy, inflammation, oxidative stress. This review aims explore the therapeutic potential plant-derived bioactive antioxidants in mitigating heart aging. These compounds, often rich polyphenols, flavonoids, other phytochemicals, exhibit notable antioxidant, anti-inflammatory, cardioprotective properties. substances have intricate properties, ability scavenge ROS, enhance endogenous antioxidant defenses, regulate signaling pathways, impede fibrosis inflammation-promoting processes. By focusing on molecular linked cardiac aging, produced from plants provide significant promise reduce age-related decline improve general health. Through comprehensive analysis preclinical clinical studies, this work highlights associated with promising effects antioxidants. The findings may helpful for researchers identifying specific molecules preventive heart.

Язык: Английский

Процитировано

0

Is Senolytic Therapy in Cardiovascular Diseases Ready for Translation to Clinics? DOI Creative Commons
Zhihong Yang, Duilio Michele Potenza, Xiu‐Fen Ming

и другие.

Biomolecules, Год журнала: 2025, Номер 15(4), С. 545 - 545

Опубликована: Апрель 8, 2025

Aging is a predominant risk factor for cardiovascular diseases. There evidence demonstrating that senescent cells not only play significant role in organism aging but also contribute to the pathogenesis of diseases younger ages. Encouraged by recent findings elimination pharmacogenetic tools could slow down and even reverse animal models, senolytic drugs have been developed, translation results from basic research clinical settings has initiated. Because numerous studies literature show beneficial therapeutic effects targeting cardiomyopathies associated with ischemia/reperfusion atherosclerotic vascular disease, are considered next generation therapies disorders. However, reported controversial or detrimental caused approaches, including worsening cardiac dysfunction, instability plaques, an increase mortality which challenges therapy into practice. This brief review article will focus on (1) analyzing discussing approaches (2) future directions questions essential understand controversies translate preclinical

Язык: Английский

Процитировано

0